Site Search
Professionals 700 results
Capabilities 89 results
Practice Area
Trial skills matter—even in a world where few disputes ever see the inside of a courtroom. Winston has built a reputation as a trial lawyers’ firm, featuring seasoned litigators who leverage extensive courtroom experience to meet our clients’ business and legal objectives. Our long history of taking cases to trial—and winning—provides our clients with tremendous settlement leverage with their adversaries, as well as a substantial likelihood of a favorable resolution if, and when, they go to trial.
Practice Area
Tax Controversy & Criminal Tax
Our Tax Controversy attorneys advise and represent clients in every aspect of federal and state tax investigations, as well as the criminal tax enforcement process. This includes the Internal Revenue Service’s (IRS) multi-jurisdictional examinations and administrative appeals, U.S. Competent Authority representations, post appeals mediation, and trial court and appellate litigation in every federal court hearing a tax matter.
Practice Area
Securities, M&A & Corporate Governance Litigation
In today’s market, litigators with experience in securities, corporate governance, and M&A-related (collectively, “securities litigation”) matters need to leverage their broad experience to serve as both advocate and as counsel and strategist, focused on helping clients to overcome not just a legal issue but a collective business problem. Given the frequent interplay between things such as corporate-control transactions, public offerings, activist shareholders, the use of complex derivatives and other financial instruments, bad news impacting stock performance, regulatory inquiries and investigations, and insurance coverage, strategic and tactical litigation decisions can have a wide-ranging impact on the success of a given transaction, as well as on companies, their boards, senior management, and advisors.
Experience 101 results
Experience
|September 8, 2025
Winston represents a class of professional swimmers alleging World Aquatics (WA) violated antitrust laws by blocking their participation in the competing International Swimming League. After WA won summary judgment, Winston successfully appealed, arguing the court applied improper antitrust standards and wrongly denied certification of a damages class. In September 2024, the Ninth Circuit reversed both rulings, reviving all claims and issuing a landmark ruling on the possible application of the per se rule or quick look review to sports-associations rules. Am Law awarded Winston “Litigator of the Week” Runner-Up recognition for the win. In November 2024, the Ninth Circuit denied rehearing. In April 2025, the district court certified a damages class.
Experience
|July 30, 2025
Represent Norman W. Fries, Inc. d/b/a Claxton Poultry Farms in a series of 15+ antitrust class actions consolidated in the Northern District of Illinois and brought by plaintiffs who allege that Claxton and the nation’s other largest poultry producers conspired to fix the price of broiler chickens in a scheme from 2008 to 2016 that raised the price for broiler chickens by artificially reducing supply.
Experience
|June 8, 2025
Secured, with co-counsel, final approval of an historic settlement of over US$2.75B in back-damages for current and former college-athletes and a new revenue-sharing model allowing schools to share future earnings with athletes. This decade-long effort across four different lawsuits redefines the economics of college sports, affirming athlete rights and fair compensation. Following a 9-0 Supreme Court victory in Alston v. NCAA, the team filed three antitrust class actions, resulting in a groundbreaking settlement that creates a revenue-sharing system projected to generate at least US$20B in new, previously prohibited payments and benefits to Division I college athletes over the next decade. The settlement was recognized in Am Law‘s Litigator of the Week column.
Insights & News 5,176 results
Seminar/CLE
|January 22, 2026
14th ITA-IEL-ICC Joint Conference on International Energy Arbitration – Houston
Imad Khan is a proud Co-Chair of The Institute for Transnational Arbitration (ITA), Institute for Energy Law (IEL) and International Chamber of Commerce (ICC) International Court of Arbitration 14th edition of what has become the premier conference on international arbitration in the energy sector. Speakers from around the globe and across the industry will gather to focus on the key issues in the field today.
Recognitions
|October 30, 2025
|Less Than 1 Min Read
Winston & Strawn Recognized in 2026 Benchmark Litigation
Winston & Strawn has been recognized in the 2026 edition of Benchmark Litigation, which covers the litigation and disputes market in North America. The firm is recognized for its excellence in litigation in the following categories:
False Claims Act Playbook
|October 30, 2025
|5 Min Read
On October 15, 2025, the United States District Court for the District of Nebraska (the Court) dismissed Pharos Capital Group and its related investment funds (Pharos Capital) from a qui tam or whistleblower suit brought under the antiretaliation provision of the False Claims Act (31 U.S.C. § 3730(h)) (the FCA), against Pharos Capital and Charter Health Care Group (Charter), a portfolio company of Pharos Capital.
Other Results 119 results
Law Glossary
What Is Advertising Litigation?
Advertising litigation is defined as the legal area that covers false or deceptive advertising cases. Lawsuits may be brought by government agencies or corporate competitors based on the Lanham Act—a law that specifically deals with false advertising. The Act outlines how an advertisement can be deemed false. The Federal Trade Commission (FTC) has the ability to file lawsuits to halt deceptive advertising claims. The U.S. Food and Drug Administration may also pursue advertising litigation against violators of government regulations. Companies may be called on to substantiate their advertising claims, whether these are made in print or online.
Law Glossary
What Are the Patent Litigation Differences Between the BPCIA and Hatch-Waxman Act?
There are fundamental differences between the abbreviated approval processes to obtain FDA approval for biosimilars and generic drugs as those processes relate to patent litigation.